The Net Margin of SK Biopharmaceuticals Co Ltd (326030.KS) is 43.96%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 43.96% |
| 2023-12-31 | -9.27% |
| 2022-12-31 | -56.64% |
| 2021-12-31 | 15.49% |
| 2020-12-31 | -951.63% |
| 2019-12-31 | -57.75% |
| 2018-12-31 | -12565.60% |
| 2017-12-31 | -114.46% |